Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Patrick Chu & Shalal Sadullah. (2009) The current role of amphotericin B lipid complex in managing systemic fungal infections. Current Medical Research and Opinion 25:12, pages 3011-3020.
Read now
Read now
TE Corcoran. (2009) Aerosol drug delivery in lung transplant recipients. Expert Opinion on Drug Delivery 6:2, pages 139-148.
Read now
Read now
PH Chandrasekar. (2008) Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate. Therapeutics and Clinical Risk Management 4:6, pages 1285-1294.
Read now
Read now
Faouzi Saliba & Bertrand Dupont. (2008) Renal impairment and Amphotericin B formulations in patients with invasive fungal infections. Medical Mycology 46:2, pages 97-112.
Read now
Read now
Karen Moeremans & Lieven Annemans. (2006) Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients. Expert Opinion on Pharmacotherapy 7:14, pages 1931-1943.
Read now
Read now
Rodrigo Martino, Montserrat Cortés, Maricel Subirá, Rocio Parody, Estela Moreno & Jorge Sierra. (2005) Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies. Leukemia & Lymphoma 46:10, pages 1429-1435.
Read now
Read now
Adolfo C Fernandez-Obregon, Janelle Rohrback, Michael Aaron Reichel & Carolyn Willis. (2005) Current use of anti-infectives in dermatology. Expert Review of Anti-infective Therapy 3:4, pages 557-591.
Read now
Read now
Articles from other publishers (22)
Shobha Kumari, Vikash Kumar, Ritesh Kumar Tiwari, Vidyanand Ravidas, Krishna Pandey & Ashish Kumar. (2022) Amphotericin B: A drug of choice for Visceral Leishmaniasis. Acta Tropica 235, pages 106661.
Crossref
Crossref
Rosilene Rodrigues Santiago, Kattya Gyselle de Holanda e Silva, Nednaldo Dantas dos Santos, Julieta Genre, Viviane Freitas de Oliveira Lione, André Leandro Silva, Henrique Rodrigues Marcelino, Amanda Duarte Gondim & Eryvaldo Sócrates Tabosa do Egito. (2018) Nanostructured lipid carriers containing Amphotericin B: Development, in vitro release assay, and storage stability. Journal of Drug Delivery Science and Technology 48, pages 372-382.
Crossref
Crossref
Beatriz Bustamante, Jose A. Hidalgo & Pablo E. Campos. 2017. Current Progress in Medical Mycology. Current Progress in Medical Mycology
29
89
.
Rima Moghnieh, Nabila El-Rajab, Dania Issam Abdallah, Ismail Fawaz, Anas Mugharbil, Tamima Jisr & Ahmad Ibrahim. (2016) Retrospective Analysis on the Use of Amphotericin B Lipid Complex in Neutropenic Cancer Patients with Suspected Fungal Infections in Lebanon, a Single Center Experience and Review of International Guidelines. Frontiers in Medicine 2.
Crossref
Crossref
Roman Lehner, Xueya Wang, Stephan Marsch & Patrick Hunziker. (2013) Intelligent nanomaterials for medicine: Carrier platforms and targeting strategies in the context of clinical application. Nanomedicine: Nanotechnology, Biology and Medicine 9:6, pages 742-757.
Crossref
Crossref
Iman Karimzadeh, Hossein Khalili, Shadi Farsaei, Simin Dashti-Khavidaki & Mohammad Mahdi Sagheb. (2013) Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity. European Journal of Clinical Pharmacology 69:7, pages 1351-1368.
Crossref
Crossref
M. S. Buckley, C. S. Anderson, S. A. Patel, M. J. Yerondopoulos, L. M. Wicks & M. T. Martin. (2013) Apparent lack of cross-reactivity for infusion-related reactions between two forms of lipid-based amphotericin B. American Journal of Health-System Pharmacy 70:12, pages 1047-1051.
Crossref
Crossref
Richard J. Hamill. (2013) Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity. Drugs 73:9, pages 919-934.
Crossref
Crossref
L. Belkherroubi-Sari, H. Adida, A. Seghir, Z. Boucherit & K. Boucherit. (2013) New strategy for enhancing the therapeutic index of Fungizone ®. Journal de Mycologie Médicale 23:1, pages 3-7.
Crossref
Crossref
Matteo Bassetti, Franco Aversa, Filippo Ballerini, Fabio Benedetti, Alessandro Busca, Nicola Cascavilla, Ercole Concia, Andrea Tendas, Francesco Di Raimondo, Patrizio Mazza, Anna Maria Nosari & Giuseppe Rossi. (2011) Amphotericin B Lipid Complex in the Management of Invasive Fungal Infections in Immunocompromised Patients. Clinical Drug Investigation 31:11, pages 745-758.
Crossref
Crossref
Cristina Giordano, Paola Gianella, Stefano Bo, Antonella Vercelli, Chiara Giudice, Daniele Delia Santa, Anna Maria, Claudio Peruccio & Andrea Peano. (2010)
Invasive Mould Infections of the Naso-Orbital Region of Cats: A Case Involving
Aspergillus Fumigatus
and an Aetiological Review
. Journal of Feline Medicine and Surgery 12:9, pages 714-723.
Crossref
Crossref
J.J. Torrado, R. Espada, M.P. Ballesteros & S. Torrado-Santiago. (2008) Amphotericin B Formulations and Drug Targeting. Journal of Pharmaceutical Sciences 97:7, pages 2405-2425.
Crossref
Crossref
R. Espada, S. Valdespina, M. A. Dea, G. Molero, M. P. Ballesteros, F. Bolás & J. J. Torrado. (2008) In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation. Journal of Antimicrobial Chemotherapy 61:5, pages 1125-1131.
Crossref
Crossref
V. V. Belakhov & Yu. D. Shenin. (2007) Synthesis and antifungal activity of N-benzyl derivatives of amphotericin B. Pharmaceutical Chemistry Journal 41:7, pages 362-366.
Crossref
Crossref
Georg Maschmeyer, Antje Haas & Oliver A Cornely. (2007) Invasive Aspergillosis. Drugs 67:11, pages 1567-1601.
Crossref
Crossref
Rodrigo Martino & Claudio Viscoli. (2005) Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin. British Journal of Haematology 132:2, pages 138-154.
Crossref
Crossref
A. Antoniadou & B. Dupont. (2005) Lipid formulations of amphotericin B: where are we today?. Journal de Mycologie Médicale 15:4, pages 230-238.
Crossref
Crossref
Arun Chandu, Richard J. MacIsaac, Duncan P. MacGregor, Matthew C. Campbell, Michael J. Wilson & Leon A. Bach. (2005) A case of mucormycosis limited to the parotid gland. Head & Neck 27:12, pages 1108-1111.
Crossref
Crossref
Diane Burgess & Siddhesh Patil. 2005. Injectable Dispersed Systems. Injectable Dispersed Systems
249
303
.
M. Simitsopoulou, E. Roilides, J. Dotis, M. Dalakiouridou, F. Dudkova, E. Andreadou & T. J. Walsh. (2005) Differential Expression of Cytokines and Chemokines in Human Monocytes Induced by Lipid Formulations of Amphotericin B. Antimicrobial Agents and Chemotherapy 49:4, pages 1397-1403.
Crossref
Crossref
Valdir S. Amato, Ana Rabello, Alexandre Rotondo-Silva, Adriana Kono, Tânia Patrícia H. Maldonado, Isabel C. Alves, Lucile M. Floeter-Winter, Vicente Amato Neto & Maria Aparecida Shikanai-Yasuda. (2004) Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients. Acta Tropica 92:2, pages 127-132.
Crossref
Crossref
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:9.
Crossref
Crossref